Over the past decade, advancements in diabetes treatment and care in the United States have been vast, implicating the potential for a significant improvement of population health outcomes. However, many factors can influence the ability of a patient to receive adequate medical care – including accessibility, geographic location, and cost – and oftentimes marginalized demographics experience difficulties with securing effective treatment. While developments in the field may greatly benefit patients with dependable access to care, advances in diabetes treatment can only have a positive impact on public health outcomes if they effectively reach all at-risk populations.
Maternal diabetes, if not treated adequately, may increase the risk of several serious health complications in children. Epidemiologic data suggest that maternal pre-existing type 1, type 2, or gestational diabetes can influence the risk for autism spectrum disorders (ASDs) in offspring. Hyperglycemia in utero increases uterine inflammation, oxidative stress, and hypoxia, potentially altering gene expression and disrupting fetal brain development, which increases the risk for neural behavior disorders. According to current estimates, 1 in 59 children is affected by autism and the prevalence of the disorder continues to rise steadily. Read more